SelSym Biotech
SelSym Biotech is dedicated to developing innovative therapeutics to address critical clinical needs in hemorrhage control, surgical bleeding, and wound healing. Their mission is to transform patient care and outcomes through advanced technologies like their Hemostatic Healing Hydrogels and SymClot, a novel therapy that mimics platelet functions to enhance hemorrhage control and address platelet supply shortages.
What We Do
SymClot is a synthetic platelet technology that mimics key functions of native platelets in hemostasis and wound healing. It targets wound sites specifically and induces clot retraction, reducing blood loss and improving wound healing outcomes. SymClot is designed for safety, functionality, and ease of storage, providing a reliable supply of hemostatic therapeutics.
SelSym Biotech’s Hemostatic Healing Hydrogels (H3) are designed to address a wide range of clinical needs in bleeding management and wound healing, including hemorrhage control, drug delivery, infection control, and long-term healing support for chronic wounds.